Supply Antibiotics Raw Material CAS 80214 -83-1 99% Powder Roxithromycin

<sub>Producta name:Roxithromycin 

CAS No.:80214-83-1</sub>

_{Other Names:Roxithromycin}

_{MF:C41H76N2O15}

_{EINECS No.:N/M}

_{Place of Origin: Anhui,China (Mainland)}

_{Type:Antipyretic Analgesics and NSAIDs, Immune Function Agents}

_{Grade Standard:Medicine Grade}

_{Usage:Animal Pharmaceuticals, Pharmaceutical intermediates}

_{Purity:96%min}

_{Appearance:White Powder}

_{Standard:BP/EP}

_{Shelf life:2 Years}

_{Package:25 Kg/drum}

<sub>Roxithromycin  is a semi-synthetic macrolide antibiotic. It is used to treat respiratory tract, urinary and soft tissue infections. Roxithromycin is derived from erythromycin, containing the same 14-membered lactone ring. However, an N-oxime side chain is attached to the lactone ring. It is also currently undergoing clinical trials for the treatment of male-pattern hair loss.

Roxithromycin is a semi-synthetic macrolide antibiotic. It is very similar in composition, chemical structure and mechanism of action to erythromycin, azithromycin, or clarithromycin. Roxithromycin has the following antibacterial spectrum in vitro: Streptococcus agalactiae,Streptococcus pneumoniae (Pneumococcus), Neisseria meningitides (Meningococcus), Listeria monocytogenes, Mycoplasma pneumoniae, Chlamydia trachomatis, Ureaplasma urealyticum,Legionella pneumophila, Helicobacter (Campylobacter), Gardnerella vaginalis, Bordetella pertussis, Moraxella catarrhalis (Branhamella Catarrhalis), and Haemophilus ducreyi. Roxithromycin is highly concentrated in polymorphonuclear leukocytes and macrophages, achieving intracellular concentrations greater than those outside the cell.

Roxithromycin enhances the adhesive and chemotactic functions of these cells which in the presence of infection produce phagocytosis and bacterial lysis. Roxithromycin also possesses intracellular bactericidal activity.</sub>